DEFA14A: ProAssurance to be Acquired by The Doctors Company, Creating Second Largest Medical Malpractice Insurer

ProAssurance has agreed to be acquired by The Doctors Company, creating the second-largest medical malpractice insurance company in the US.

Summary

• ProAssurance has agreed to be acquired by The Doctors Company.
• The merger will create the second-largest medical malpractice insurance company in the country and the largest physician-owned carrier.
• The transaction is expected to close in the first half of 2026, pending shareholder and regulatory approvals.
• The combined company aims to be the preferred choice for distribution partners and healthcare clients.
• The Doctors Company's Tribute Plan has awarded over $175 million to over 13,500 recipients since 2007.

Sentiment

Score: 7

Explanation: The document conveys a positive outlook on the merger, highlighting benefits for partners and clients. However, it also acknowledges risks and uncertainties associated with the transaction, resulting in a moderately positive sentiment score.

Positives

• The merger will create a financially stable entity to face challenges like social inflation.
• The combined company will offer a wider range of product options for healthcare providers.
• The agent/broker distribution model will continue to be a priority.
• The Doctors Company's Tribute Plan offers a loyalty program for physicians.

Negatives

• The transaction is subject to shareholder and regulatory approvals, which could delay or prevent the merger.
• There are risks associated with integrating the two companies.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.

Risks

• The completion of the proposed transaction on the anticipated terms and timing is not guaranteed.
• The stock price of ProAssurance Corporation may fluctuate during the pendency of the proposed transaction.
• Potential litigation relating to the proposed transaction could be instituted against ProAssurance Corporation or its directors, managers or officers.
• Disruptions from the proposed transaction will harm ProAssurance Corporations business, including current plans and operations, including during the pendency of the proposed transaction.
• The ability of ProAssurance Corporation to retain and hire key personnel may be impacted.
• Management's time and attention may be diverted from ordinary course business operations to completion of the proposed transaction and integration matters.
• Potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed transaction that could affect ProAssurance Corporations financial performance.
• Restrictions during the pendency of the proposed transaction may impact ProAssurance Corporations ability to pursue certain business opportunities or strategic transactions.
• The proposed transaction may be more expensive to complete than anticipated.
• Unexpected costs, liabilities or delays associated with the transaction may arise.
• Competitors may respond to the transaction in a way that is unfavorable to ProAssurance Corporation.
• An event, change or other circumstance could give rise to the termination of the proposed transaction, including in circumstances requiring ProAssurance Corporation to pay a termination fee.

Future Outlook

The combined company aims to be the premier medical malpractice company and the preferred choice of distribution partners and healthcare clients, with increased financial stability to face challenges like social inflation.

Management Comments

• We believe this transaction will be beneficial to our distribution partners and their clients and is appropriate given the rapidly consolidating healthcare and broker industries.
• You and your clients can expect a continuation of all services you are receiving from ProAssurance at the same high standards and dedication to excellence.
• You will see no change in our commitment to the agent/broker distribution model nor to the incentive and recognition programs we have in place for 2025.
• We believe our combined strengths will now create the premier medical malpractice company and be the preferred choice of our distribution partners and healthcare clients.
• The financial stability created by combining our companies will help us face the challenges of the ever-increasing environment of social inflation and shock verdicts.

Industry Context

The announcement comes amid a rapidly consolidating healthcare and broker industry, with the merger positioning the combined entity as a major player in the medical malpractice insurance market, competing with other national companies.

Comparison to Industry Standards

• The combined organization will be the second largest medical malpractice insurance company in the country.
• The combined organization will be the largest physician-owned carrier.
• The Doctors Company and ProAssurance are in a group of medical professional liability specialist insurance companies that were founded by physicians during the liability crisis of the 1970s and grew over 50 years through the acquisition of other physician-specialist insurers to become national companies.

Stakeholder Impact

• Shareholders will vote on the proposed acquisition.
• Agency partners can expect a continuation of services.
• Clients are expected to benefit from the combined strengths of the two companies.
• Employees may experience changes as the companies integrate.

Next Steps

• ProAssurance shareholders must approve the transaction.
• Regulators, including insurance regulators in several states, must approve the transaction.
• Antitrust clearance must be received.
• Business Development leadership will review all current broker agreements and determine the best path forward.

Key Dates

Keywords

ProAssurance, The Doctors Company, merger, acquisition, medical malpractice insurance, insurance, healthcare, insurance agency, brokerage firm